Feng L, Shi Q, Wang S, Zhao Y, et al. The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study. BMC Cancer 2024;24:1267.
PMID: 39394089